DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Metrolotion (Metronidazole Topical) - Side Effects and Adverse Reactions



In a controlled clinical trial, safety data from 141 patients who used MetroLotion® Topical Lotion (n=71), or the lotion vehicle (n=70), twice daily and experienced a local cutaneous adverse event which may or may not have been related to the treatments include: local allergic reaction, MetroLotion® Topical Lotion 2 (3%), lotion vehicle 0; contact dermatitis, MetroLotion® Topical Lotion 2 (3%), lotion vehicle 1 (1%); pruritus, MetroLotion® Topical Lotion 1 (1%), lotion vehicle 0; skin discomfort (burning and stinging), MetroLotion® Topical Lotion 1 (1%), lotion vehicle 2 (3%); erythema, MetroLotion® Topical Lotion 4 (6%), lotion vehicle 0; dry skin, MetroLotion® Topical Lotion 0, lotion vehicle 1 (l%); and worsening of rosacea, MetroLotion® Topical Lotion 1 (1%), lotion vehicle 7 (10%).

The following additional adverse experiences have been reported with the topical use of metronidazole: skin irritation, transient redness, metallic taste, tingling or numbness of extremities, and nausea.

Drug label data at the top of this Page last updated: 2004-07-25

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017